Inhibition of Neutrophil Superoxide Secretion By of Preservative, Methylhydroxybenzoate: Effects Mediated By Perturbation of Intracellular Ca²⁺?

References

• Blum K., Futterman S., Wallace J. E.L., Schwertner H. A. Naloxone-induced inhibition of ethanol dependence in mice. Nature 1977; 265: 49–51
   PubMed Web of Science ®Google Scholar
• Sørensen S. C., Mattison K. Naloxone as an antagonist in severe alcohol intoxication. Lancet 1978; ii: 688
   Google Scholar
• Jeffcoate W. J., Herbert M., Cullen M. H., Hastings A. G., Walder C. P. Prevention of effects of alcohol intoxication by Naloxone. Lancet 1979; ii: 1157–1159
   Google Scholar
• Jeffreys D. B., Flanagan R. J., Volans G. N. Reversal of ethanol-induced coma with Naloxone. Lancet 1980; i: 308–309
   Google Scholar
• Caldecourt M. A., Palmer T. N., Steare S. E., Sugden M. C., Watts D. I. Is the direct effect of naloxone on liver cell metabolism an artifact?. Biochemica et Biophysica Acta 1983; 759: 300–305
   Google Scholar
• Dingley A. L., Holmquist B., Valle B. L. Narcan inhibition of human liver alcohol dehydrogenase. Biochemical and Biophysical Research Communications 1985; 131: 299–306
   PubMedGoogle Scholar
• Soulioti A. M.A., Leonard M., Rodger I. W. Does naloxone induce relation of guinea pig airway smooth muscle?. Journal of Pharmacy and Pharmacology 1986; 38: 702–705
   PubMedGoogle Scholar
• Brandt I., Andersson K.-E., Hindselt B., Lungsren B., Pickard J. D. Are the vascular effects of naloxone attributable to the preservatives of methyl-propyl paraben?. Journal of Cerebral Blood Flow 1983; 3: 395–398
   PubMedGoogle Scholar
• Soulioti A. M.A., Cobbold P. H. Do the preservatives methyl and propyl hydroxbenzoate activate protein kinase C?. British Journal of Pharmacology 1988; 9: 212
   Google Scholar
• Soulioti A. M.A., Woods N. M., Cobbold P. H., Rodger I. W. Preservatives in the vehicle of naloxone: pharmacological effects. Biomedicine and Pharmacotherapy 1989; 43: 771–778
   PubMedGoogle Scholar
• Curnutte J. T. Phagocyte defects II: abnormalities of the respiratory burst. Hematology/Oncology Clinics of North America 1988; 2: 185–336
   Google Scholar
• Roct P., Silverman H., Plump D., Kecala Z., Smith P., Michael J. R., Summer W. Efficacy and safety of naloxone in septic shock. Critical Care Medicine 1985; 13: 28–33
   PubMedGoogle Scholar
• DeMaria A., Craven D. E., Heffernan J. J., McIntosh T. K., Grindlinger G. A., McCabe W. R. Naloxone versus placebo in treatment of septic shock. Lancet 1985; i: 1363–1365
   Google Scholar
• Bonnet F., Bilaine J., Lhoste F., Mankikian B., Kerdelhue B., Rapin M. Naloxone therapy of human septic shock. Critical Care Medicine 1985; 13: 972–975
   PubMedGoogle Scholar
• Mamazza J., Hinchey E. F., Chiu R. C.-J. The pulmonary effects of opiate blockade in septic shock. Journal of Surgical Research 1984; 36: 625–630
   PubMedGoogle Scholar
• Simpkins C. O., Ives N., Johnson M., Tate E., Chernow B. Naloxone inhibits superoxide release in human neutrophils. Critical Care Medicine 1985; 13: 328
   Google Scholar
• Edwards S. W., Say J. E., Hart C. A. Oxygen-dependent killing of Staphylococcus aureus human neutrophils. Journal of General Microbiology 1987; 133: 3591–3597
   PubMedGoogle Scholar
• Babior B. M., Kipnes R. S., Curnutte J. T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bacteriocidal agent. Journal of Clinical Investigation 1973; 52: 741–744
   PubMed Web of Science ®Google Scholar
• Geiger R., Fritz H. Methods of Enzymatic Analysis, 3rd Edition, H. U. Bergmeyer. Verlag Chemie GmbH. 1984; 119–124
   Google Scholar
• Hallett M. B., Campbell A. K. Two distinct mechanisms for stimulation of oxygen-radical production by polymorphonuclear leucocytes. Biochemical Journal 1983; 216: 459–465
   PubMedGoogle Scholar
• Al-Mohanna F. A., Hallett M. B. The use of fura-2 to determine the relationship between cytoplasmic free Ca2+ and oxidase activation in rat neutrophils. Cell Calcium 1988; 9: 17–26
   PubMedGoogle Scholar
• Dahlgren C. Difference in extracellular radical release after chemotactic factor and calcium ionophore activation of the oxygen radical-generating system in human neutrophils. Biochemica et Biophysica Acta 1987; 930: 33–38
   PubMedGoogle Scholar
• Tsien R. Y., Pozzan T., Rink T. J. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium measured with a new, intracellularly trapped fluorescent indicator. Journal of Cell Biology 1982; 94: 325–334
   PubMed Web of Science ®Google Scholar
• Baggiolini M., Wyman M. P. Turning on the respiratory burst. TIBS 1990; 15: 69–72
   PubMed Web of Science ®Google Scholar
• Grinstein S., Furuya W. Receptor-mediated activation of electropermealised neutrophils. Evidence for a Ca2+ -and protein kinase C-independent signalling pathway. Journal of Biological Chemistry 1988; 263: 1779–1783
   PubMedGoogle Scholar
• Lackie J. M., Lawrence A. J. Signal response transduction in rabbit neutrophil leucocytes. The effects of exogenous phopholipase A2 suggests two pathways exist. Biochemical Pharmacology 1987; 36: 1941–1945
   PubMedGoogle Scholar
• Reinhold S. L., Prescott S. M., Zimmerman G. A., McIntyre T. M. Activation of human neutrophil phopholipase D by three separable mechanisms. FASEB Journal 1990; 4: 208–214
   PubMed Web of Science ®Google Scholar
• Nurcombe H. L., Edwards S. W. Role of myeloperoxidase in intra- and extra-cellular chemiluminescence of neutrophils. Annals of the Rheumatic Diseases 1989; 48: 56–62
   PubMed Web of Science ®Google Scholar
• Alexander K. S., Petersen H., Jr., Turcotte T. J.G., Paruta A. N. Molecular orbital calculations for parabens: a possible mechanism of action. Journal of Pharmaceutical Science 1976; 65: 851–855
   PubMedGoogle Scholar
• Rickard J. E., Sheterline P. Evidence that phorbol ester interferes with stimulated Ca2+ redistribution by activating Ca2+ efflux in neutrophil leukocytes. Biochemical Journal 1985; 231: 623–628
   PubMedGoogle Scholar
• Pontremoli S., Melloni E. Extralysosomal protein degradation. Annual Reviews of Biochemistry 1986; 55: 455–481
   PubMedGoogle Scholar